Le Lézard
Classified in: Health, Business
Subjects: TNM, AWD

Westbury Group Recognized as One of Axial's Top 50 Healthcare M&A Advisors


The Westbury Group is honored to announce its selection as one of Axial's Top 50 Healthcare M&A Advisors.

WESTPORT, Conn., May 6, 2024 /PRNewswire-PRWeb/ -- The Westbury Group is honored to announce its selection as one of Axial's Top 50 Healthcare M&A Advisors. This prestigious recognition underscores the firm's dedication, expertise, and outstanding contributions to the healthcare mergers and acquisitions landscape.

"We are immensely proud to be named among Axial's Top 50 Healthcare M&A Advisors. This acknowledgment is a testament to our team's unwavering commitment to delivering superior advisory services and driving successful outcomes for our clients in the healthcare sector." - Dr. Patrick Huddie, Partner

Axial, a leading platform connecting private companies with capital, has recognized The Westbury Group for its exceptional performance and influence within the healthcare sector. The Top 50 list comprises firms that have demonstrated unparalleled proficiency, strategic insight, and transactional success in facilitating mergers and acquisitions within the lower-middle-market healthcare industry.

"We are immensely proud to be named among Axial's Top 50 Healthcare M&A Advisors," said Dr. Patrick Huddie, Partner at The Westbury Group. "This acknowledgment is a testament to our team's unwavering commitment to delivering superior advisory services and driving successful outcomes for our clients in the healthcare sector."

The Westbury Group's inclusion in Axial's prestigious list reaffirms its position as a trusted partner and advisor to healthcare companies seeking strategic mergers, acquisitions, and divestitures. With a proven track record of navigating complex transactions and providing tailored solutions, the firm continues to set benchmarks for excellence in the healthcare M&A advisory space.

"As we celebrate this achievement, we extend our heartfelt gratitude to our clients for their continued trust and confidence in our capabilities," added Jonathan Rubin. "This recognition energizes us to uphold our commitment to delivering exceptional value and strategic guidance as we navigate the evolving landscape of healthcare mergers and acquisitions."

For more information about The Westbury Group and its comprehensive range of healthcare advisory services, please visit www.westburygroup.com.

About The Westbury Group:

The Westbury Group is a leading boutique advisory firm specializing in mergers and acquisitions, capital raising, and strategic advisory services for middle-market companies across various industries, with a focus on the healthcare sector. With a team of seasoned professionals and a client-centric approach, The Westbury Group is committed to delivering tailored solutions and driving successful outcomes for its clients.

Media Contact:

Jonathan Rubin, Partner

Westbury Group LLC

+1 (203) 883-9000

[email protected]

Media Contact

Jonathan Rubin, Westbury Group, 1 2038839000 105, [email protected], www.westburygroup.com

SOURCE Westbury Group


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: